By David Warmflash

Our society, and to some extent even clinical medicine, is focused on blood lipoproteins, especially low density lipoprotein (LDL, the “bad” cholesterol). LDL is at center stage for assessment of one’s risk, and also as a blood value to modify with drugs, such as statins, and dietary change. There are good reasons for this, but another serum value, triglycerides, also plays a key role, yet how many people are aware of their “trig” level? Continue reading →

Andrew Porterfield has a master’s degree in biotechnology management from the University of Maryland and has worked as a marketing communications consultant for many biotechnology and pharmaceutical firms.

While most arguments about cranberries this holiday season revolve around “berries” or “jelly,” another debate is taking place among drug-makers and researchers: what medicinal value does this little dark red, sour fruit offer? Continue reading →

Follow Blog via Email

Enter your email address to follow this blog and receive notifications of new posts by email.